Form: 10-Q

Quarterly report [Sections 13 or 15(d)]

July 19, 2021

Documents

Exhibit 10.15

 

CONFIRMATION OF RESCISSION OF NOTE AMENDMENTS

 

On November 27, 2020 and February 10, 2021, 180 Life Corp., CannBioRex Pharma Ltd. and CannBioRex Pharma Corp., each director or indirect subsidiaries of 180 Life Sciences Corp., a Delaware corporation (the “Companies”), entered into 18 Amendment to Loan Agreements with Sir Marc Feldmann, as more fully described in Exhibit A (collectively, the “Note Amendments”).

 

The Note Amendments were entered into in error, and by their execution of this Confirmation of Rescission of Note Amendments below, Sir Marc Feldmann and the Companies, agree, confirm and acknowledge that:

 

● The Note Amendments were entered into error and did not reflect the agreement of the parties thereto;

 

● Such Note Amendments are rescinded and terminated, effective as of the applicable dates set forth under “Date of Amendment” on Exhibit A (the “Effective Date”, as applicable); and

 

● The effect of this Confirmation of Rescission of Note Amendments shall be as if such Note Amendments were never entered into by the parties, never effective and never binding, effective as of the Effective Date (as applicable).

 

    180 Life Corp.
       
    By: /s/ James Woody 
       
    Printed Name: James Woody
       
    Its: CEO 180 Life Sciences
       
    CannBioRex Pharma Ltd.
       
    By: /s/ Ozan Pamir
       
    Printed Name: Ozan Pamir
       
    Its: CFO 
       
    CannBioRex Pharma Corp.
       
    By: /s/ Ozan Pamir
       
    Printed Name:  Ozan Pamir
       
    Its: CFO
 /s/ Marc Feldmann    
Sir Marc Feldmann    

 

 

 

 

EXHIBIT A

 

Number   Noteholder Name   Date of
Amendment		   Borrower   Currency   Amount     Date of Original Note
1   Sir Marc Feldmann   2/10/2021   180 Life Corp.   GBP     60,000     10/20/2019
2   Sir Marc Feldmann   2/10/2021    CannBioRex Pharma Ltd.   GBP     5,198.18     2/28/2019
3   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     40,000     10/29/2019
4   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     10,000     10/29/2019
5   Sir Marc Feldmann   2/10/2021    CannBioRex Pharma Ltd.   GBP     15,029.78     11/27/2019
6   Sir Marc Feldmann   2/10/2021   CannBioRex Pharma Corp.   CAD     10,000     12/11/2019
7   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     137,381     1/20/2020
8   Sir Marc Feldmann   2/10/2021    CannBioRex Pharma Ltd.   GBP     5,193.18     1/30/2020
9   Sir Marc Feldmann   2/10/2021    CannBioRex Pharma Ltd.   GBP     14,111.43     2/28/2020
10   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     1,871.75     4/2/2020
11   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     1,563.75     4/2/2020
12   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     12,905     4/13/2020
13   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     7,889.75     5/30/2020
14   Sir Marc Feldmann   11/27/2020    CannBioRex Pharma Ltd.   GBP     6,712.31     8/26/2020
15   Sir Marc Feldmann   2/10/2021   181 Life Corp.   GBP     5,833.33     4/28/2020
16   Sir Marc Feldmann   2/10/2021   180 Life Corp.   GBP     5,193.18     10/30/2019
17   Sir Marc Feldmann   2/10/2021   180 Life Corp.   USD     1,961     5/19/2020
18   Sir Marc Feldmann   2/10/2021   180 Life Corp.   GBP     5,833.33     5/29/2020